SCHEMBL20924783

SCHEMBL20924783

CCCC(=O)OC(CCCCCCCCC(=O)OC1CCC2CCCCC2CC1)CCCCCCCCC(=O)OC1CCC2CCCCC2C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAAA Q02083 2/20 0.51
▸ MAPT P10636 2/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ LMNA P02545 4/20 0.37
▸ ALDH1A1 P00352 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ EPHX2 P34913 1/20 0.35
▸ PRKCA P17252 1/20 0.34
▸ PRKCE Q02156 1/20 0.34
▸ PRKCQ Q04759 1/20 0.34
▸ PRKCD Q05655 1/20 0.34
▸ LPAR3 Q9UBY5 3/20 0.33
▸ ENPP2 Q13822 2/20 0.33
▸ LPAR2 Q9HBW0 2/20 0.33
▸ LPAR1 Q92633 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ GMNN O75496 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ BLM P54132 1/20 0.33
▸ KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15028144 0.87 NAAA (0.40) NAAAMAPTMAPK1LMNAALDH1A1
SCHEMBL16380565 0.82 NAAA (0.49) NAAAMAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL20924811 0.81 NAAA (0.36) NAAASMN1; SMN2
SCHEMBL16376168 0.80 NAAA (0.47) NAAALMNAALDH1A1SMN1; SMN2EPHX2
SCHEMBL7900619 0.77 NAAA (0.82) NAAALMNASMN1; SMN2PRKCA
SCHEMBL20924765 0.77 NAAA (0.58) NAAAMAPTMAPK1LMNAALDH1A1
SCHEMBL31634377 0.76 MAPK1 (0.48) NAAAMAPTMAPK1LMNAALDH1A1
SCHEMBL20924712 0.76 NAAA (0.57) NAAAMAPTMAPK1LMNAALDH1A1
SCHEMBL29190226 0.75 NAAA (0.64) NAAAMAPTMAPK1LMNAALDH1A1
SCHEMBL15009586 0.75 NAAA (0.54) NAAAMAPTMAPK1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2788316-B1 BRANCHED ALKYL AND CYCLOALKYL TERMINATED BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS ALNYLAM PHARMACEUTICALS INC (US) 2019-04-24 — — EP disclosed
Send feedback